| ID | Name | CAS |
MW (g/mol) |
| 116-035-4 |
O,O,O-Tris(tert-butyldimethylsilyl)uridine
|
64898-15-3 | 586.98 |
| 83-032-4 |
Octadeca-9,12,15-trienoic acid docosyl ester, Z,Z,Z
|
| 587.01 |
| 90-529-5 |
Docosanoic acid octadeca-9,12,15-trienyl ester, Z,Z,Z
|
| 587.01 |
| 67-733-4 |
Thromboxane B2, tris-TMS
|
| 587.02 |
| 26-731-1 |
1, 1'-Thiobis(2-methyl-4-tert-butyldimethylsilyloxy-5-tert-butylbenzene)
|
| 587.06 |
| 97-222-8 |
5-Pregnen-3«beta»,17«alpha»,20«alpha»-triol, (VDMS)3
|
| 587.07 |
| 72-787-9 |
Biotin, N,N'-tert-butyldimethylsilyl-, tert-butyldimethylsilyl ester
|
| 587.09 |
| 47-387-1 |
Diethylmalonic acid, 1-bromo-3,3,3-trifluoroprop-2-yl octadecyl ester
|
| 587.59 |
| 78-955-6 |
Perfluoroundecane
|
| 588.08 |
| 52-547-7 |
Diethylmalonic acid, di(2,2,3,3,4,4,5,5-octafluoropentyl) ester
|
| 588.28 |
| 111-734-3 |
Etoposide (148-167,25mg/ml)
|
| 588.56 |
| 17-070-5 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy-trimethylsilane
|
| 588.80 |
| 13-677-6 |
3«beta»-Hydroxy-7-oxo-5-cholestenoate, MeTMS
|
| 589.01 |
| 58-050-2 |
3-oxy-7«alpha»-hydroxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
| 589.01 |
| 40-696-5 |
7«alpha»-Hydroxy-3-oxo-4-cholestenoate, MeTMS
|
| 589.01 |
| 14-551-4 |
Docosanoic acid octadeca-9,12-dienyl ester, Z
|
| 589.03 |
| 90-531-2 |
(Z)-(Z)-icos-11-en-1-yl icos-11-enoate
|
173443-70-4 | 589.03 |
| 60-736-8 |
Octadeca-9,12-dienoic acid docosyl ester, Z
|
| 589.03 |
| 45-810-2 |
Cytidine, buto-oxime-TMS derivative
|
| 589.04 |
| 21-158-3 |
(20S)-3«beta»,29-bis-(Trimethylsilyloxy)lupane
|
| 589.09 |
| 31-089-9 |
3«beta»,20-bis-(Trimethylsilyloxy)lupane
|
| 589.09 |
| 22-212-1 |
(20R)-3«beta»,29-bis-(Trimethylsilyloxy)lupane
|
| 589.09 |
| 78-149-1 |
Benzenesulfonamide, p-[2-[(6-amino-2,3-diphenylpyrido[2,3-b]pyrazin-8-yl)amino]ethyl]-n,n-diethyl-, monohydrochloride
|
21395-47-1 | 589.15 |
| 72-394-5 |
Sebacic acid, di(2,4,6-trichlorobenzyl) ester
|
| 589.16 |
| 73-558-2 |
Benzamide, 2,4,5-trifluoro-3-methoxy-N-(2,4,5-trifluoro-3-methoxybenzoyl)-N-tetradecyl-
|
| 589.61 |
| 61-707-9 |
Ceramide 18:1/18:0 methaneboronate
|
| 589.78 |
| 30-007-0 |
2,2'',4,4',4'',6,6',6''-Octanitro-m-terphenyl
|
33491-88-2 | 590.28 |
| 50-998-9 |
Heptadecafluorononanoic acid, nonyl ester
|
| 590.32 |
| 75-209-7 |
3-(2,4,5-Trichlorophenoxy)-1,2-propanediol-bis-2,2,3-trichloropropionate
|
100961-23-7 | 590.32 |
| 95-087-1 |
Sebacic acid, di(1-(pentafluorophenyl)ethyl) ester
|
| 590.45 |
| 57-809-1 |
Isophthalic acid, 2,2,3,3,4,4,5,5-octafluoropentyl pentadecyl ester
|
| 590.59 |
| 50-958-3 |
Tetratriacontyl trifluoroacetate
|
| 590.93 |
| 32-741-3 |
Quercetin, 5,7,3',4'-tetra-TMS
|
| 590.96 |
| 124-035-5 |
Quercetin, 3,7,3',4'-tetra-TMS
|
| 590.96 |
| 50-192-3 |
3«beta»,7«beta»-Dihydroxy-5-cholestenoate, MeTMS
|
| 591.02 |
| 17-167-8 |
3«beta»,7a-Dihydroxy-5-cholestenoate, MeTMS
|
| 591.02 |
| 19-367-4 |
Methyl 7-«alpha»,12-«alpha»-dihydroxy-4-cholestenoate, TMS
|
| 591.02 |
| 90-528-6 |
Docosanoic acid octadec-9-enyl ester, Z
|
| 591.05 |
| 83-031-5 |
Octadec-9-enoic acid docosyl ester, Z
|
| 591.05 |
| 22-850-3 |
7,11,19-trimethylnonatriacontane
|
| 591.13 |
| 47-794-9 |
13,17,21,25-Tetramethylheptatriacontane
|
| 591.13 |
| 64-967-8 |
Tetracontane, 13,17-dimethyl
|
| 591.13 |
| 26-311-7 |
13,17,21-trimethylnonatriacontane
|
| 591.13 |
| 13-968-3 |
5,9,13-trimethylnonatriacontane
|
| 591.13 |
| 32-547-9 |
Dotetracontane
|
7098-20-6 | 591.13 |
| 74-602-1 |
9,15,19-trimethylnonatriacontane
|
| 591.13 |
| 64-121-6 |
9,13,19-trimethylnonatriacontane
|
| 591.13 |
| 17-000-2 |
8,16,22,28-tetramethyloctatriacontane
|
| 591.13 |
| 14-918-7 |
21-methylhentetracontane
|
| 591.13 |
| 48-208-8 |
17-methylhentetracontane
|
| 591.13 |
| 24-484-8 |
Nonatriacontane, 11,15,19-trimethyl
|
| 591.13 |
| 74-601-2 |
8,12,20,26-tetramethyloctatriacontane
|
| 591.13 |
| 74-600-3 |
Octadecane, 2,2,4,15,17,17-hexamethyl-7,12-bis(3,5,5-trimethylhexyl)-
|
55470-97-8 | 591.13 |
| 60-263-3 |
13,21,25-trimethyl-nonatriacontane
|
| 591.13 |
| 51-886-2 |
5,13,17-Trimethylnonatriacontane
|
| 591.13 |
| 18-359-4 |
15,19,23-trimethylnonatriacontane
|
| 591.13 |
| 79-963-6 |
8,12,18,22-tetramethyloctatriacontane
|
| 591.13 |
| 16-371-2 |
6,10,24,28-tetramethyloctatriacontane
|
| 591.13 |
| 76-331-0 |
6,10,14,20-tetramethyloctatriacontane
|
| 591.13 |
| 67-315-8 |
10,14,18,22-Tetramethyloctatriacontane
|
| 591.13 |
| 38-611-1 |
13,19,25-Trimethylnonatriacontane
|
| 591.13 |
| 74-599-6 |
13,17,25-trimethyl-nonatriacontane
|
| 591.13 |
| 79-962-7 |
19-methylhentetracontane
|
| 591.13 |
| 123-256-1 |
Propanoic acid, pentafluoro-, 4-[2-[(2,2,3,3,3-pentafluoro-1-oxopropyl)amino]ethyl]-1,2-phenylene ester
|
59785-38-5 | 591.23 |
| 112-953-9 |
Octopamine, tri-PFP
|
62237-94-9 | 591.23 |
| 32-875-5 |
Nickel octaethylporphyrin
|
24803-99-4 | 591.45 |
| 26-585-4 |
Co-OEP complex
|
17632-19-8 | 591.69 |
| 121-178-0 |
3-hydroxy-4-methylglutamic acid, N(O,S)-isoBOC TBDMS, diastreoisomer 2
|
| 591.88 |
| 114-581-0 |
3-hydroxy-4-methylglutamic acid, N(O,S)-isoBOC TBDMS, diastreoisomer 1
|
| 591.88 |
| 15-015-8 |
Cortisone, MO-TMS
|
| 591.93 |
| 52-264-1 |
Ketogluconic acid methyl ester, tetrakis(trifluoroacetate) (isomer 2)
|
| 592.20 |
| 32-436-2 |
Ketogluconic acid methyl ester, tetrakis(trifluoroacetate) (isomer 1)
|
| 592.20 |
| 33-446-0 |
Ketogluconic acid methyl ester, tetrakis(trifluoroacetate) (isomer 3)
|
| 592.20 |
| 37-152-2 |
2,2,3,3,4,4,4-Heptafluoro-N-[4-[4-(2,2,3,3,4,4,4-heptafluorobutanoylamino)phenoxy]phenyl]butanamide
|
| 592.28 |
| 77-486-8 |
Pentadecafluorooctanoic acid, tridec-2-yn-1-yl ester
|
| 592.38 |
| 37-660-8 |
«alpha»-Hydroxynervonic acid, HFB-Me
|
| 592.67 |
| 65-411-3 |
GA3-3«beta»-O-glucoside, permethylated
|
| 592.67 |
| 40-853-0 |
GA3-13-O-glucoside, permethylated
|
| 592.67 |
| 57-210-5 |
Diethylmalonic acid, octadecyl pentafluorobenzyl ester
|
| 592.72 |
| 121-003-3 |
Succinic acid, eicosyl 1-(pentafluorophenyl)ethyl ester
|
| 592.72 |
| 123-280-4 |
Sebacic acid, pentadecyl pentafluorobenzyl ester
|
| 592.72 |
| 26-674-5 |
Heptacosyl heptafluorobutyrate
|
| 592.76 |
| 29-405-0 |
GA39 3-isovalerate, methyl ester TMS
|
| 592.79 |
| 122-245-4 |
5-Hydroxytryptophan, ethoxycarbonylated, TBDMS # 2
|
| 592.87 |
| 17-800-4 |
GA87, MeTMSi
|
| 592.94 |
| 17-826-6 |
12-«beta»-Hydroxy-GA3, MeTMSi
|
| 592.94 |
| 29-256-6 |
12-«alpha»-Hydroxy-GA3 = GA87, Me-TMS
|
| 592.94 |
| 18-837-3 |
15-«beta»-Hydroxy-GA3, MeTMSi
|
| 592.94 |
| 29-463-6 |
3-(Octadecyloxy)propyl oleate
|
| 593.02 |
| 69-828-7 |
3-«alpha»,7-«alpha»-Dihydroxy-5-«beta»-cholestanoic acid, methyl ester, TMS
|
| 593.04 |
| 37-009-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
| 593.04 |
| 60-575-7 |
Eicosanoic acid, eicosyl ester
|
22432-80-0 | 593.06 |
| 83-029-8 |
Octadecanoic acid, docosyl ester
|
22413-03-2 | 593.06 |
| 46-559-1 |
octadecyl docosanoate
|
24271-12-3 | 593.06 |
| 74-578-9 |
1-Hentetracontanol
|
40710-42-7 | 593.11 |
| 67-973-8 |
2,3,16,17-Tetrakis[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (16«alpha»,17«beta»)-
|
51497-46-2 | 593.11 |
| 29-972-1 |
15(ksi)-Hydroxyoestriol, TMS
|
| 593.11 |
| 29-504-0 |
Cyclooctasiloxane, hexadecamethyl-
|
556-68-3 | 593.23 |
| 10-826-3 |
Nickel-octaethylporphyrine complex
|
| 593.47 |
| 119-108-0 |
Benzamide, 3-fluoro-5-trifluoromethyl-N-(3-fluoro-5-trifluoromethylbenzoyl)-N-tetradecyl-
|
| 593.59 |
|
« Previous Results
Next Results »
|